nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A5—Dactinomycin—ocular cancer	0.746	1	CbGbCtD
Epinephrine—ADRA1A—Signaling Pathways—TFDP1—ocular cancer	0.000124	0.000489	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—E2F3—ocular cancer	0.000124	0.000489	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—E2F1—ocular cancer	0.000124	0.000487	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAML2—ocular cancer	0.000122	0.00048	CbGpPWpGaD
Epinephrine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000122	0.00048	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—CDKN1B—ocular cancer	0.000121	0.000478	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CDKN1A—ocular cancer	0.000121	0.000478	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GNA11—ocular cancer	0.000121	0.000477	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAML2—ocular cancer	0.000121	0.000476	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—AKT1—ocular cancer	0.00012	0.000472	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAML2—ocular cancer	0.000119	0.00047	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GNA11—ocular cancer	0.000118	0.000464	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GNA11—ocular cancer	0.000117	0.00046	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TFDP1—ocular cancer	0.000116	0.000455	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EP300—ocular cancer	0.000116	0.000454	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000115	0.000454	CbGpPWpGaD
Epinephrine—PAH—Disease—HRAS—ocular cancer	0.000115	0.000451	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000114	0.000448	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAML2—ocular cancer	0.000113	0.000445	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GNA11—ocular cancer	0.000113	0.000445	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GNAQ—ocular cancer	0.000113	0.000443	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—CDKN1A—ocular cancer	0.000112	0.000441	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAML2—ocular cancer	0.000111	0.000438	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—TGFB1—ocular cancer	0.00011	0.000434	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—HRAS—ocular cancer	0.00011	0.000433	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GNAQ—ocular cancer	0.00011	0.000431	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GNAQ—ocular cancer	0.000109	0.000428	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EP300—ocular cancer	0.000107	0.00042	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GNA11—ocular cancer	0.000107	0.000419	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GNA11—ocular cancer	0.000106	0.000415	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GNAQ—ocular cancer	0.000105	0.000413	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GNA11—ocular cancer	0.000104	0.00041	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—EP300—ocular cancer	0.000104	0.000409	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—HRAS—ocular cancer	0.000103	0.000404	CbGpPWpGaD
Epinephrine—PAH—Disease—AKT1—ocular cancer	0.000101	0.000398	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GNAQ—ocular cancer	9.91e-05	0.00039	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAML2—ocular cancer	9.88e-05	0.000389	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GNA11—ocular cancer	9.86e-05	0.000388	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GNAQ—ocular cancer	9.82e-05	0.000386	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HDAC1—ocular cancer	9.8e-05	0.000385	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—EP300—ocular cancer	9.72e-05	0.000382	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GNA11—ocular cancer	9.71e-05	0.000382	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GNAQ—ocular cancer	9.69e-05	0.000381	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GNA11—ocular cancer	9.58e-05	0.000377	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MDM2—ocular cancer	9.32e-05	0.000366	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MYC—ocular cancer	9.3e-05	0.000366	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—TGFB1—ocular cancer	9.27e-05	0.000365	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	9.25e-05	0.000364	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAML2—ocular cancer	9.18e-05	0.000361	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GNAQ—ocular cancer	9.17e-05	0.000361	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TGFB1—ocular cancer	9.04e-05	0.000356	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GNAQ—ocular cancer	9.02e-05	0.000355	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HDAC1—ocular cancer	8.93e-05	0.000351	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GNAQ—ocular cancer	8.91e-05	0.00035	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HDAC1—ocular cancer	8.85e-05	0.000348	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN2B—ocular cancer	8.78e-05	0.000346	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HDAC1—ocular cancer	8.73e-05	0.000344	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—HRAS—ocular cancer	8.69e-05	0.000342	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HRAS—ocular cancer	8.65e-05	0.00034	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GNA11—ocular cancer	8.62e-05	0.000339	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CDKN1B—ocular cancer	8.51e-05	0.000335	CbGpPWpGaD
Epinephrine—PAH—Metabolism—AKT1—ocular cancer	8.47e-05	0.000333	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TGFB1—ocular cancer	8.45e-05	0.000332	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—AKT1—ocular cancer	8.42e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HDAC1—ocular cancer	8.26e-05	0.000325	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HDAC1—ocular cancer	8.13e-05	0.00032	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CCND1—ocular cancer	8.12e-05	0.000319	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—E2F1—ocular cancer	8.06e-05	0.000317	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GNAQ—ocular cancer	8.01e-05	0.000315	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GNA11—ocular cancer	8.01e-05	0.000315	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	8e-05	0.000315	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN2B—ocular cancer	7.93e-05	0.000312	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HRAS—ocular cancer	7.91e-05	0.000311	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—EP300—ocular cancer	7.89e-05	0.00031	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CDKN1A—ocular cancer	7.85e-05	0.000309	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	7.83e-05	0.000308	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—AKT1—ocular cancer	7.67e-05	0.000302	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—AKT1—ocular cancer	7.64e-05	0.000301	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MDM2—ocular cancer	7.48e-05	0.000294	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EP300—ocular cancer	7.47e-05	0.000294	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GNAQ—ocular cancer	7.45e-05	0.000293	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—ocular cancer	7.45e-05	0.000293	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN2B—ocular cancer	7.41e-05	0.000291	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—E2F1—ocular cancer	7.35e-05	0.000289	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HRAS—ocular cancer	7.3e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN2B—ocular cancer	7.29e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—E2F1—ocular cancer	7.28e-05	0.000286	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	7.22e-05	0.000284	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—E2F1—ocular cancer	7.19e-05	0.000283	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—HRAS—ocular cancer	7.12e-05	0.00028	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—AKT1—ocular cancer	6.98e-05	0.000275	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—ocular cancer	6.95e-05	0.000274	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HRAS—ocular cancer	6.95e-05	0.000273	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TGFB1—ocular cancer	6.86e-05	0.00027	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CDKN1B—ocular cancer	6.83e-05	0.000269	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—E2F1—ocular cancer	6.8e-05	0.000267	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—AKT1—ocular cancer	6.76e-05	0.000266	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	6.71e-05	0.000264	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—E2F1—ocular cancer	6.69e-05	0.000263	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—HRAS—ocular cancer	6.65e-05	0.000262	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCND1—ocular cancer	6.52e-05	0.000256	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—ocular cancer	6.51e-05	0.000256	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFB1—ocular cancer	6.49e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	6.48e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—AKT1—ocular cancer	6.45e-05	0.000254	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CDKN1A—ocular cancer	6.3e-05	0.000248	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—AKT1—ocular cancer	6.29e-05	0.000247	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNA11—ocular cancer	6.19e-05	0.000243	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—AKT1—ocular cancer	6.14e-05	0.000241	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	6.02e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EP300—ocular cancer	6e-05	0.000236	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	5.94e-05	0.000234	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—AKT1—ocular cancer	5.87e-05	0.000231	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNAQ—ocular cancer	5.75e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—ocular cancer	5.65e-05	0.000222	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—E2F1—ocular cancer	5.52e-05	0.000217	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—ocular cancer	5.4e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—ocular cancer	5.35e-05	0.00021	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNA11—ocular cancer	5.29e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—ocular cancer	5.23e-05	0.000206	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—ocular cancer	5.21e-05	0.000205	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—ocular cancer	5.11e-05	0.000201	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNAQ—ocular cancer	4.92e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	4.87e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—ocular cancer	4.77e-05	0.000188	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.64e-05	0.000183	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	4.53e-05	0.000178	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—ocular cancer	4.51e-05	0.000178	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	4.45e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MDM2—ocular cancer	4.44e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	4.4e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MDM2—ocular cancer	4.4e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MDM2—ocular cancer	4.34e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—ocular cancer	4.29e-05	0.000169	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	4.24e-05	0.000167	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	4.12e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	4.11e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	4.11e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—ocular cancer	4.1e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	4.09e-05	0.000161	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNA11—ocular cancer	4.08e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	4.05e-05	0.000159	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—EP300—ocular cancer	4.05e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	4.04e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	4.03e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	4.02e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	4.01e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	4e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	3.97e-05	0.000156	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.97e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	3.97e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—EP300—ocular cancer	3.94e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	3.92e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EP300—ocular cancer	3.91e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—ocular cancer	3.87e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	3.83e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	3.82e-05	0.00015	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNAQ—ocular cancer	3.79e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—ocular cancer	3.78e-05	0.000149	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—EP300—ocular cancer	3.78e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	3.76e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	3.75e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	3.74e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	3.71e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	3.71e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	3.69e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	3.66e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	3.65e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	3.64e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—ocular cancer	3.62e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	3.61e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	3.59e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	3.58e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	3.56e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EP300—ocular cancer	3.56e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EP300—ocular cancer	3.53e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	3.52e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EP300—ocular cancer	3.48e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	3.46e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	3.41e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—ocular cancer	3.4e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	3.4e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	3.37e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	3.34e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	3.34e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	3.32e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EP300—ocular cancer	3.29e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	3.28e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	3.24e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EP300—ocular cancer	3.24e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—EP300—ocular cancer	3.2e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	3.13e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—ocular cancer	3.1e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	3.1e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	3.09e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—ocular cancer	3.07e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	3.07e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	3.05e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—ocular cancer	3.03e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	3.03e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	3.03e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	3.01e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	2.95e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	2.91e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EP300—ocular cancer	2.88e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—ocular cancer	2.87e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	2.86e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—ocular cancer	2.83e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	2.82e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	2.81e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—ocular cancer	2.8e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	2.74e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EP300—ocular cancer	2.68e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	2.67e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—ocular cancer	2.55e-05	0.0001	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—ocular cancer	2.52e-05	9.93e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—ocular cancer	2.51e-05	9.87e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	2.5e-05	9.85e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—ocular cancer	2.49e-05	9.8e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—ocular cancer	2.45e-05	9.63e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—ocular cancer	2.44e-05	9.58e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	2.41e-05	9.49e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—ocular cancer	2.38e-05	9.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—ocular cancer	2.38e-05	9.37e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	2.36e-05	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—ocular cancer	2.36e-05	9.27e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—ocular cancer	2.33e-05	9.17e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	2.33e-05	9.15e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—ocular cancer	2.32e-05	9.13e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—ocular cancer	2.28e-05	8.97e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	2.25e-05	8.87e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	2.22e-05	8.73e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—ocular cancer	2.15e-05	8.46e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	2.13e-05	8.38e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—ocular cancer	2.1e-05	8.28e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—EP300—ocular cancer	2.07e-05	8.13e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—ocular cancer	2.06e-05	8.11e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	1.99e-05	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	1.97e-05	7.75e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	1.96e-05	7.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—ocular cancer	1.93e-05	7.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—ocular cancer	1.92e-05	7.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	1.83e-05	7.2e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—EP300—ocular cancer	1.77e-05	6.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	1.74e-05	6.85e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	1.62e-05	6.36e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—EP300—ocular cancer	1.36e-05	5.36e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—ocular cancer	1.25e-05	4.91e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—ocular cancer	1.07e-05	4.2e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—ocular cancer	8.24e-06	3.24e-05	CbGpPWpGaD
